Andrew Weiss is currently a Disease Area Leader at Roche, overseeing global commercial strategies in immunology and infectious disease since 2025. Previously, Weiss worked at Novartis as a Principal Scientist in drug discovery, specializing in the design of novel therapeutics, and held several key roles at Genentech, where they led market analysis and strategy for neuroscience products and managed launches for critical therapeutics. Weiss also contributed as a Scientific Advisor at Wilson Sonsini Goodrich & Rosati, focusing on patent strategy in pharmaceutical chemistry. They earned a Ph.D. in Chemistry from Stanford University and completed a postdoctoral fellowship at Harvard University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices